Approval marks Harrison.ai's second out of three Breakthrough designations to reach marketing authorization, and 9 th FDA clearance covering a total of 13 radiological findings. SYDNEY & BOSTON, March ...
Cerebral amyloid angiopathy (CAA) is a condition where protein (called amyloid) builds up in the brain, making blood vessels weak. People with CAA are four times more likely to develop dementia within ...
The Chosun Ilbo on MSN
Taiwan Student Dies of Cerebral Rupture After Four-Day Gaming
A man in his 20s in Taiwan died from a cerebral blood vessel rupture after playing video games nonstop for four days and ...
South Korea’s MFDS gave regulatory clearance to SK Inc. C&C’s artificial intelligence (AI) solution to diagnose cerebral infarction called Medical Insight+ Brain Infarct on Feb. 22, as a class III ...
Even patients with acute ischemic stroke who are delayed in getting to the hospital and already have large cerebral infarcts may derive a benefit from endovascular therapy to remove the clot, ...
The first international trial of an unproven stroke treatment available in the U.S. has concluded that, while harmless, "perispinal" etanercept—injected into the spinal area—is no more effective than ...
Factor XIa inhibitor milvexian did not provide meaningful secondary prevention over dual antiplatelet therapy for stroke survivors, the phase II trial AXIOMATIC-SSP found. In patients with recent ...
A secondary analysis of the phase 2 PACIFIC-STROKE trial showed that asundexian is effective for the secondary prevention of stroke in patients with stroke of atherosclerotic origin, but not those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results